Aethlon Medical's stockholders approved an amendment to increase the number of shares in the 2020 Equity Incentive Plan by 3 million shares during the Annual Meeting on September 27, 2024, where 36.14% of shares were represented. Additionally, five directors were elected and the appointment of Haskell & White LLP as the independent auditor was ratified.